{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:56:56Z","timestamp":1785520616944,"version":"3.56.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s13318-019-00558-8","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T15:41:49Z","timestamp":1557502909000},"page":"681-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetics and Safety of a Diclofenac Sodium 75\u00a0mg\/1\u00a0mL Solution (Akis\u00ae\/Dicloin\u00ae) Administered as a Single Intravenous Bolus Injection in Healthy Men and Women"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-6029","authenticated-orcid":false,"given":"Chiara","family":"Leuratti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Loprete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Frangione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Rovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milko","family":"Radicioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"558_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0014-2999(94)90398-0","volume":"251","author":"CR Tonussi","year":"1994","unstructured":"Tonussi CR, Ferreira SH. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur J Pharmacol. 1994;251:173\u20139.","journal-title":"Eur J Pharmacol"},{"key":"558_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2165\/00003495-198020010-00002","volume":"20","author":"RN Brogden","year":"1980","unstructured":"Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs. 1980;20:24\u201348.","journal-title":"Drugs."},{"issue":"3","key":"558_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2165\/00003088-199733030-00003","volume":"33","author":"NM Davies","year":"1997","unstructured":"Davies NM, Keith EA. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet. 1997;33(3):184\u2013213.","journal-title":"Clin Pharmacokinet"},{"key":"558_CR4","unstructured":"IBSA Farmaceutici Italia Srl. Summary of product characteristics of Akis\u00ae 75\u00a0mg\/mL solution for injection in prefilled syringe. \n                    https:\/\/www.medicines.org.uk\/emc\/product\/9399\/smpc\n                    \n                  . Accessed 18 Jan 2019."},{"issue":"2","key":"558_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/ALN.0b013e31823c1030","volume":"116","author":"American Society of Anesthesiologists Task Force on Acute Pain Management","year":"2012","unstructured":"American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012;116(2):248\u201373. \n                    https:\/\/doi.org\/10.1097\/aln.0b013e31823c1030\n                    \n                  .","journal-title":"Anesthesiology"},{"issue":"2","key":"558_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","volume":"17","author":"R Chou","year":"2016","unstructured":"Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists\u2019 Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17(2):131\u201357. \n                    https:\/\/doi.org\/10.1016\/j.jpain.2015.12.008\n                    \n                  . Erratum. In: J Pain. 2016;17(4):508-10. Dosage error in article text. PubMed PMID: 26827847.","journal-title":"J Pain."},{"key":"558_CR7","unstructured":"European Medicines Agency. Guideline on the investigation of bioequivalence (CPMP\/EWP\/QWP\/1401\/98 Rev. 1\/Corr **, 20 January 2010). \n                    https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/guideline-investigation-bioequivalence-rev1_en.pdf\n                    \n                  . Accessed 18 Jan 2019."},{"key":"558_CR8","unstructured":"Novartis Pharmaceuticals UK Ltd. Summary of product characteristics of Voltarol\u00ae 75\u00a0mg\/1\u00a0mL solution for injection in ampoules (marketing authorisation number: PL 00101\/0466). \n                    https:\/\/www.medicines.org.uk\/emc\/product\/1043\/smpc\n                    \n                  . Accessed 23 Jan 2019."},{"key":"558_CR9","unstructured":"Medicines and Healthcare Products Regulatory Agency. Dyloject\u00ae 75\u00a0mg\/2\u00a0mL solution for injection (PL 25053\/0001). \n                    http:\/\/www.mhra.gov.uk\/home\/groups\/par\/documents\/websiteresources\/con2033165.pdf\n                    \n                  . Accessed 13 Jul 2018."},{"issue":"10","key":"558_CR10","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/phar.1304","volume":"33","author":"F Mermelstein","year":"2013","unstructured":"Mermelstein F, Hamilton DA, Wright C, Lacouture PG, Ramaiya A, Carr DB. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HP\u03b2CD-diclofenac (Dyloject\u00ae) compared with other diclofenac formulations. Pharmacotherapy. 2013;33(10):1012\u201321. \n                    https:\/\/doi.org\/10.1002\/phar.1304\n                    \n                  .","journal-title":"Pharmacotherapy."},{"key":"558_CR11","unstructured":"European Medicines Agency. Guideline on bioanalytical method validation (EMEA\/CHMP\/EWP\/192217\/2009 Rev.1 Corr.* 21JUL2011). \n                    https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf\n                    \n                  . Accessed 23 Jan 2019."},{"key":"558_CR12","unstructured":"US Food and Drug Administration. Guidance for industry: bioanalytical method validation (2001). \n                    https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm070107.pdf\n                    \n                  . Accessed 23 Jan 2019."},{"issue":"4","key":"558_CR13","first-page":"68","volume":"94","author":"A Jackson","year":"1998","unstructured":"Jackson A. Infection control: a battle in vein infusion phlebitis. Nurs Times. 1998;94(4):68.","journal-title":"Nurs Times."},{"key":"558_CR14","unstructured":"Medicines and Healthcare Products Regulatory Agency. E(10) A\/11 Ref: MDR 41-05\/10. 21MAY2010 (Drug Alert No. 11: Class 2 Medicines Recall). \n                    https:\/\/www.sehd.scot.nhs.uk\/publications\/dc20100521drugalert11.pdf\n                    \n                  . Accessed 23 Jan 2019."},{"key":"558_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00115550-200707000-00006","volume":"32","author":"RM Leeson","year":"2007","unstructured":"Leeson RM, Harrison S, Ernst CC, Hamilton DA, Mermelstein FH, Gawarecki DG, Moshman M, Carr DB. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperatve dental pain. Reg Anesth Pain Med. 2007;32:303\u201310.","journal-title":"Reg Anesth Pain Med"},{"key":"558_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2344\/0003-3006-58.2.73","volume":"58","author":"K Christensen","year":"2011","unstructured":"Christensen K, Daniels S, Bandy D, Ernst CC, Hamilton DA, Mermelstein FH, Wang J, Carr DB. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesth Prog. 2011;58:73\u201381.","journal-title":"Anesth Prog"},{"key":"558_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.acpain.2008.11.001","volume":"11","author":"RD Colucci","year":"2009","unstructured":"Colucci RD, Wright C IV, Mermelstein FH, Gawarecki DG, Carr DB. Dyloject\u00ae, a novel injectable diclofenac solubilised with cyclodextrin: reduced incidence of thrombophlebitis compared to injectable diclofenac solubilised with polyethylene glycol and benzyl alcohol. Acute Pain. 2009;11:15\u201321.","journal-title":"Acute Pain."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-019-00558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-019-00558-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-019-00558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:22:29Z","timestamp":1588965749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-019-00558-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1007\/s13318-019-00558-8","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"10 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}